-
Indian Healthcare Firms learn the lesson from US Debacle
There’s a lesson in here for the Indian government—both the…
Read more -
Government’s priority is to reduce healthcare cost’ – Union Minister for Overseas Indian Affairs Vayalar Ravi
Union Minister for Overseas Indian Affairs Vayalar Ravi interacting with…
Read more -
How a good regulator can turn the fortunes of the paralysed clinical trial industry
Early this week, the Supreme Court raised serious concerns over…
Read more -
Slowdown could be attributed to the new drug pricing policy and the regulatory interventions over last year – See more at: http://www.businessworld.in/news/business/pharma/pharma-industry-not-in-pink-of-health/1136565/page-1.html#sthash.chqhLvjL.dpuf
Increased regulatory interventions and price controls have pulled down the…
Read more -
Indian Pharma Company Flying High!
Although global economic recovery still remains fragile and the road…
Read more -
Incredible Pharmaleaders 2013 – Billion Dreams. Pushing India’s Growth Agenda
Incredible Pharmaleaders 2013. – “ Pushing India’s Growth Agenda-” is…
Read more -
Medical tourism to generate $3 billion by 2013 – report
Medical Tourism Debate in Pharmaleaders India is emerging as the…
Read more -
Pharmaleaders 2013 Award
Innovation With Sparking Discovery will Drive Pharmaleaders at 6th Annual…
Read more -
Manufacturing continued to be the main source of wealth in India with 17 per cent of the rich list, followed by pharmaceuticals and real estate, which have both seen their percentages drop slightly to 11 per cent and nine per cent, down from 12 per cent and 10 per cent respectively.
Pharmaceutical sector accounted for 11 per cent of super rich…
Read more -
Top 20 Indian pharma cos set up 545 subsidiaries, 25 of them post net sales of Rs.50,181 cr in 2012-13
India’s top 20 pharmaceutical companies have established a record number…
Read more